- SPM-927 (Schwarz Pharma).
SPM-927 (Schwarz Pharma).
IDrugs : the investigational drugs journal (2003-06-06)
Collin A Hovinga
PMID12789603
ABSTRACT
Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.